CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,333,145 | +84.1% | 34,677 | +10.8% | 0.00% | +50.0% |
| Q1 2023 | $724,248 | +13.2% | 31,285 | +28.1% | 0.00% | 0.0% |
| Q4 2022 | $639,621 | +63.6% | 24,413 | +22.8% | 0.00% | +100.0% |
| Q3 2022 | $391,000 | +70.7% | 19,887 | +51.4% | 0.00% | 0.0% |
| Q2 2022 | $229,000 | – | 13,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |